NCT01875107

Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Minnesota · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on weight, given to pregnant patients with gestational or preexisting diabetes receiving betamethasone can provide adequate glycemic control. Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help maintain euglycemia for pregnant patients with gestational and preexisting diabetes after steroid administration, and possibly impact length of hospital admission.

Conditions

• Hyperglycemia in Pregnant Diabetic Patients

Interventions

Type	Name	Description
DRUG	insulin pre-treatment	insulin pre-treatment of pregnant diabetic patients who receive betamethasone

Timeline

• Start date: 2013-08-01
• Primary completion: 2014-08-01
• Completion: 2014-08-01
• First posted: 2013-06-11
• Last updated: 2014-09-12

Locations

1 site across 1 country: United States